Search clinical trials for: Tislelizumab plus Bevacizumab
Total 7588 results
-
BeiGeneMyriad Genetic Laboratories, Inc.CompletedSolid TumorsUnited States, Spain, United Kingdom, France, Australia, New Zealand
-
Beijing Friendship HospitalRecruitingLocally Advanced Rectal CancerChina
-
Beijing Friendship HospitalPeking University First Hospital; Peking University People's Hospital; Peking... and other collaboratorsRecruitingLocally Advanced Rectal CancerChina
-
Guangxi Medical UniversityCompleted
-
Chen XiaopingRecruitingHCC | Precision TherapyChina
-
Guangdong Provincial People's HospitalRecruitingHepatocellular CarcinomaChina
-
The University of Tennessee, KnoxvilleNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Cherokee...CompletedObesity | Childhood ObesityUnited States
-
ResMedCompletedSleep Apnea, Obstructive | Sleep Apnea, CentralGermany
-
Sun Yat-sen UniversityRecruitingAdvanced Hepatocellular Carcinoma | Bevacizumab | Anti-PD1/PDL1 AntibodyChina
-
Shanghai Kechow Pharma, Inc.Not yet recruitingColorectal Cancer Metastatic
-
National Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Stage IVA Cervical Cancer AJCC v6 and v7 | Recurrent Cervical Carcinoma | Stage IV Cervical Cancer AJCC v6 and v7 | Stage IVB Cervical Cancer AJCC v6 and v7United States
-
Northwestern UniversityNational Cancer Institute (NCI); Ipsen BiopharmaceuticalsCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Celldex TherapeuticsRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Serous Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Platinum-Sensitive Ovarian Carcinoma | Recurrent Fallopian... and other conditionsUnited States
-
Alma Lasers Inc.Unknown
-
Fujian Medical University Union HospitalRecruitingUrinary Bladder Neoplasms | Treatment Outcome | Neoplasm Recurrence, Local | Multicenter Study | Immunotherapy, Active | BCG VaccineChina
-
Lai-ping ZhongSun Yat-sen University; Fudan University; Fujian Medical University; Central South...RecruitingOral Squamous Cell Carcinoma | Locally Advanced Head and Neck CarcinomaChina
-
Novartis PharmaceuticalsRecruitingMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal CancersJapan, Italy, Spain, Singapore, Belgium, Germany, Korea, Republic of, Sweden, Taiwan, France, Israel, Norway, United States
-
Fujian Cancer HospitalEnrolling by invitationEGFR/ ALK-negative Advanced NSCLCChina
-
Quanli GaoRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Locally Advanced Lung Non-Small... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable MelanomaUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Prostate Carcinoma | Metastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage IV Renal... and other conditionsUnited States, Puerto Rico
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Alveolar Soft Part Sarcoma | Unresectable Alveolar Soft Part SarcomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Ovarian Endometrioid Adenocarcinoma | Ovarian Undifferentiated Carcinoma | Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Malignant Peritoneal Neoplasm | Endometrial Clear Cell Adenocarcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell... and other conditionsUnited States
-
Ethicon, Inc.Completed
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Undifferentiated Carcinoma | Fallopian Tube Carcinoma | Ovarian Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell... and other conditionsUnited States
-
BeiGeneNot yet recruiting
-
BeiGeneActive, not recruiting
-
BeiGeneCompleted
-
Zhejiang Cancer HospitalActive, not recruiting
-
Xiangdong ChengShanxi Province Cancer Hospital; The Second Affiliated Hospital of Harbin Medical... and other collaboratorsNot yet recruiting
-
BeiGeneRecruitingAdvanced Solid TumorAustralia
-
Zhongda HospitalRecruitingHepatocellular CarcinomaChina
-
BeiGeneActive, not recruitingResectable Esophageal Squamous Cell CarcinomaChina
-
BeiGeneLymphoma Study AssociationActive, not recruitingClassical Hodgkin LymphomaUnited States, Australia, France, Belgium, Puerto Rico
-
Cancer Institute and Hospital, Chinese Academy...Active, not recruitingChemotherapy | Gastric Cancer Stage IV | Tislelizumab | First-lineChina
-
CelgeneBeiGeneTerminatedCarcinoma, Non-Small-Cell LungSpain, United States, Japan, China, Canada, United Kingdom, Belgium, Singapore, Korea, Republic of, Netherlands, France, Romania, Greece, Germany, Taiwan, Finland, Italy, Poland, Hungary, Ireland, Portugal, New Zealand, Russian Federation
-
BeiGeneRecruitingMelanoma | Renal Cell Carcinoma | Urothelial CarcinomaChina
-
Farmaceutici Damor SpaRecruitingWounds and Injuries | Wound Infection | Wound HealItaly
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditionsUnited States
-
West China HospitalNot yet recruitingNSCLC Associated With Leptomeningeal Metastases
-
Qiu GuoqinEnrolling by invitationEsophageal Squamous Cell CarcinomaChina
-
Renmin Hospital of Wuhan UniversityCompletedAdvanced Gastric AdenocarcinomaChina
-
University of TrierGerman Research FoundationCompletedFeedback, PsychologicalGermany
-
Third Affiliated Hospital, Sun Yat-Sen UniversitySun Yat-sen University; Fifth Affiliated Hospital, Sun Yat-Sen University; Second... and other collaboratorsNot yet recruitingHepatocellular Carcinoma | Hepatic Portal Vein Tumor Invasion | Tumor Thrombus
-
National Cancer Institute (NCI)Active, not recruitingRecurrent GlioblastomaUnited States
-
National Cancer Institute (NCI)CompletedBrain Stem Glioma | Childhood Spinal Cord Neoplasm | Childhood Cerebral Anaplastic Astrocytoma | Cerebral Astrocytoma | Childhood Cerebellar Anaplastic AstrocytomaUnited States, Canada
-
National Institute of Diabetes and Digestive and...Completed
-
Immune-Onc TherapeuticsCompletedAdvanced Solid TumorChina